Publication | Closed Access

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial

VaccinologyVaccine SafetyCross-protectionVaccinationProtective EfficacyVaccine DevelopmentImmunologyStrain SelectionPlacebo-controlled TrialVaccine EfficacyInfluenza VaccineHealthy AdultsFlu VaccinationMedicineInfluenza Vaccines